CLN3iPSC

Ramu Venkatesan1, Paul C Trippier2

  • 1Department of Pharmaceutical Sciences, College of Pharmacy, University of Nebraska Medical Center, Omaha, NE 68106, USA.

STAR protocols
|December 13, 2025
PubMed
概括

这项研究详细介绍了一项用于选最常见的儿童神经退行性疾病 - - CLN3疾病的潜在治疗方案的方案,该方案使用来自患者的干细胞和神经元前代细胞.